Study shows that immune cells determine growth of certain tumours
A new study shows that the growth rate of a tumour does not depend solely on how quickly the cancer cells can divide.
List view / Grid view
A new study shows that the growth rate of a tumour does not depend solely on how quickly the cancer cells can divide.
An international team of researchers has proven that targeting a specific area of the flu virus protects humans.
Nuclear magnetic resonance measurement and state-of-the-art computational science reveal protein structures in higher eukaryotic cells.
New research could lead to novel treatments for autoimmune disorders and sheds light on the causes of autoimmunity.
Researchers use stem cell-based disease models to pinpoint gene linked to impaired memory in Down syndrome.
23 May 2019 | By Sartorius
Join us as we discuss the promises and pitfalls associated with developing individualised antigen-specific T-cell therapy products for clinical use.
A new method of assessing the actions of medicines by matching them to their unique protein receptors could accelerate drug development.
16 May 2019 | By
Researchers say they have affirmed inconsistencies in the use of a common laboratory procedure called immunohistochemical staining.
A new way to cleanly separate out cancer cells from a blood sample will enable comprehensive genetic profiling of the cancer cells.
In a recent study more than half of patients with advanced prostate cancers appear to be strong candidates for targeted cancer therapies.
Treatments for chronic inflammatory diseases are one step closer as a new study discovers a way to stop inflammation in its tracks.
Researchers from King's College London have found a method that can induce heart cells to regenerate after a heart attack.
Researchers are first to demonstrate in a clinically relevant model that damaged lungs can be regenerated to meet transplantation criteria.
MIT engineers have designed tiny robots that can help drug-delivery nanoparticles push their way out of the bloodstream and into a tumour or another disease site.
By silencing genes, researchers have increased the protein production in yeast, laying the grounds for engineering better yeast production hosts for industries producing biopharmaceutical proteins and industrial enzymes.